124 related articles for article (PubMed ID: 20695192)
21. The role of fibroblast growth factor 2 in patients with uterine smooth muscle tumors: an immunohistochemical study.
Bodner-Adler B; Mayerhofer K; Czerwenka K; Kimberger O; Koelbl H; Bodner K
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():62-67. PubMed ID: 27825029
[TBL] [Abstract][Full Text] [Related]
22. Bisphenol A Concentrates Preferentially in Human Uterine Leiomyoma and Induces Proliferation in Rat Myometrium.
Othman ER; Al-Adly DM; Elgamal DA; Ghandour N; El-Sharkawy S
Reprod Sci; 2016 Apr; 23(4):508-14. PubMed ID: 26445998
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of 14-3-3 protein family levels and associated receptor expression of estrogen and progesterone in human uterine leiomyomas.
Wang L; Huang H; Liu D; Fang S; Xian Y; Zhou J; Zuo Y; Wang F; Huang O; He M
Gynecol Endocrinol; 2012 Aug; 28(8):665-8. PubMed ID: 22329840
[TBL] [Abstract][Full Text] [Related]
24. Estrogen receptor alpha (ERalpha) phospho-serine-118 is highly expressed in human uterine leiomyomas compared to matched myometrium.
Hermon TL; Moore AB; Yu L; Kissling GE; Castora FJ; Dixon D
Virchows Arch; 2008 Dec; 453(6):557-69. PubMed ID: 18853184
[TBL] [Abstract][Full Text] [Related]
25. Expression of the fibroblast growth factor receptor in women with leiomyomas and abnormal uterine bleeding.
Anania CA; Stewart EA; Quade BJ; Hill JA; Nowak RA
Mol Hum Reprod; 1997 Aug; 3(8):685-91. PubMed ID: 9294852
[TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of cyclin D1 and oestrogen receptor (alpha and beta) levels in human leiomyoma and adjacent myometrium.
Kovács KA; Oszter A; Göcze PM; Környei JL; Szabó I
Mol Hum Reprod; 2001 Nov; 7(11):1085-91. PubMed ID: 11675476
[TBL] [Abstract][Full Text] [Related]
27. Possible involvement of inflammatory/reparative processes in the development of uterine fibroids.
Protic O; Toti P; Islam MS; Occhini R; Giannubilo SR; Catherino WH; Cinti S; Petraglia F; Ciavattini A; Castellucci M; Hinz B; Ciarmela P
Cell Tissue Res; 2016 May; 364(2):415-27. PubMed ID: 26613601
[TBL] [Abstract][Full Text] [Related]
28. [Basic fibroblast growth factor in leiomyoma].
Wolańska M; Sobolewski K
Pol Merkur Lekarski; 2004 Dec; 17(102):590-2. PubMed ID: 15771129
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease.
Laganà AS; Vergara D; Favilli A; La Rosa VL; Tinelli A; Gerli S; Noventa M; Vitagliano A; Triolo O; Rapisarda AMC; Vitale SG
Arch Gynecol Obstet; 2017 Nov; 296(5):855-867. PubMed ID: 28875276
[TBL] [Abstract][Full Text] [Related]
30. Magnetic resonance spectroscopy features of uterine leiomyomas.
Celik O; Sarac K; Hascalik S; Alkan A; Mizrak B; Yologlu S
Gynecol Obstet Invest; 2004; 58(4):194-201. PubMed ID: 15286450
[TBL] [Abstract][Full Text] [Related]
31. Identification of TRADD as a potential biomarker in human uterine leiomyoma through iTRAQ based proteomic profiling.
Liu Y; Lu D; Sheng J; Luo L; Zhang W
Mol Cell Probes; 2017 Dec; 36():15-20. PubMed ID: 28698006
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical localization of selected pro-inflammatory factors in uterine myomas and myometrium in women of various ages.
Plewka A; Madej P; Plewka D; Kowalczyk A; Miskiewicz A; Wittek P; Leks T; Bilski R
Folia Histochem Cytobiol; 2013; 51(1):73-83. PubMed ID: 23690221
[TBL] [Abstract][Full Text] [Related]
33. Muscle architecture in uterine leiomyomas and 5-hydroxytryptamine type 2A receptor.
Pieralli A; Andersson KL; Bussani C; Fambrini M
Int J Gynaecol Obstet; 2008 Dec; 103(3):261-2. PubMed ID: 18775534
[No Abstract] [Full Text] [Related]
34. Growth potential of human uterine leiomyomas: some in vitro observations and their implications.
Cramer SF; Robertson AL; Ziats NP; Pearson OH
Obstet Gynecol; 1985 Jul; 66(1):36-41. PubMed ID: 3892387
[TBL] [Abstract][Full Text] [Related]
35. Apoptosis, cellular proliferation and expression of p53 in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause.
Wu X; Blanck A; Olovsson M; Möller B; Favini R; Lindblom B
Acta Obstet Gynecol Scand; 2000 May; 79(5):397-404. PubMed ID: 10830768
[TBL] [Abstract][Full Text] [Related]
36. Oxytocin-induced cell growth proliferation in human myometrial cells and leiomyomas.
Busnelli M; Rimoldi V; Viganò P; Persani L; Di Blasio AM; Chini B
Fertil Steril; 2010 Oct; 94(5):1869-74. PubMed ID: 20056210
[TBL] [Abstract][Full Text] [Related]
37. Comparative effects of SPRM asoprisnil (J867) on proliferation, apoptosis, and the expression of growth factors in cultured uterine leiomyoma cells and normal myometrial cells.
Ohara N; Morikawa A; Chen W; Wang J; DeManno DA; Chwalisz K; Maruo T
Reprod Sci; 2007 Dec; 14(8 Suppl):20-7. PubMed ID: 18089606
[TBL] [Abstract][Full Text] [Related]
38. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.
Luo X; Levens E; Williams RS; Chegini N
Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906
[TBL] [Abstract][Full Text] [Related]
39. Insulin-like growth factor I and II binding in human myometrium and leiomyomas.
Chandrasekhar Y; Heiner J; Osuamkpe C; Nagamani M
Am J Obstet Gynecol; 1992 Jan; 166(1 Pt 1):64-9. PubMed ID: 1310202
[TBL] [Abstract][Full Text] [Related]
40. A novel selective progesterone receptor modulator asoprisnil activates tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated signaling pathway in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells.
Sasaki H; Ohara N; Xu Q; Wang J; DeManno DA; Chwalisz K; Yoshida S; Maruo T
J Clin Endocrinol Metab; 2007 Feb; 92(2):616-23. PubMed ID: 17105846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
